Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Identify which index funds yield the strongest after-tax returns in 2024. Learn how tax considerations impact fund performance and retirement strategy.
28,085 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Strategy has boosted its Bitcoin holdings again, financing the move by selling stock and growing its asset base. Crit...
A weekly ETF flow snapshot shows large outflows from U.S. spot Bitcoin and Ethereum ETFs even as XRP and HYPE attract...
Southeast Asia confronts a growing gap in the AI hardware value chain as global demand for AI chips climbs. Governmen...
Japan’s first female prime signals a bold pivot toward U.S. cooperation on rare earths and economic security, a move ...
Fidelity Investments’ leadership, led by Abby Johnson, has quietly built a decades-long crypto program that critics n...
Mastercard and Western Union are aligning with Solana Foundation's new enterprise toolbox to power RWAs, cross-border...
E-Estate unveils a June 13 Washington DC Summit to celebrate a year of tokenized real estate and map the sector’s inf...
Russia faces widening budget deficits as war spending outpaces revenue, pushing the economy toward a prolonged stretc...
As global markets digest a dual threat from US AI policy and China's energy choke points, the G7 confronts a politica...
Cerebras signals an upcoming IPO as it presses to outpace Nvidia and rival AI-chip startups in the fast-moving genera...
Investors are turning their attention from faster GPUs to a broader shift in AI hardware. This next stage revolution ...